not tagged
not tagged
['lymsm', 'dlbcl']
#17icml
question: what should the control arm be for future second line dlbcl trials? : car t-cells have established a new second line standard of care &amp; any new therapy that wants to enter the second line should compare itself against car t-cells #lymsm
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem